Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Más filtros

Intervalo de año de publicación
1.
Curr Eye Res ; 46(3): 398-407, 2021 03.
Artículo en Inglés | MEDLINE | ID: mdl-32730712

RESUMEN

PURPOSE: We have evaluated the potential radioprotective, antioxidant and anti-apoptotic effects of resveratrol (RSV) against high-dose radioactive iodine (RAI) therapy associated damage of the lacrimal glands by biochemical, histopathological and immunohistochemical methods. MATERIALS AND METHODS: Thirty Wistar-albino rats were randomly divided into three groups; the control group received no treatment or medication, the RAI group received RAI but no medication and the RSV group received oral RAI and intraperitoneal RSV. RSV was started at day one, before RAI administration, and continued for 8 days. Bilateral intraorbital (IG), extraorbital (EG), and Harderian (HG) lacrimal glands were evaluated in all rats for histopathological, immunohistochemical, tissue cytokine and oxidant and antioxidant level assessment. RESULTS: RSV group restored inflammation, fibrosis, vacuolization, change in nucleus characteristics, lipofuscin-like accumulation and cellular morphologic patterns were statistically significant in all lacrimal gland types, compared to the RAI group (p < .05 for all variables). Similarly, elevated Caspase-3 and TUNEL levels in the RAI group were significantly alleviated in the RSV group in all lacrimal gland types (p < .05 for all variables). RAI administration significantly elevated TNF-α, IL-6, NF-кb levels, and decreased IL-10 levels (p < .05 for all parameters) whereas TOS levels significantly increased and TAS levels were significantly decreased. However, RSV significantly diminished TNF-α, IL-6, IL-4, and NF-кb levels. Furthermore, RSV significantly decreased TOS and increased TAS levels (p < .05 for all variables). CONCLUSIONS: We conclude that with its anti-cancer effect as well as its antioxidant effect RSV has protected the histopathological pattern of the lacrimal glands from the damage, decreased inflammation in histopathologic assessments, and decreased tissue cytokine levels, apoptosis and DNA fragmentation on the lacrimal glands after RAI.


Asunto(s)
Radioisótopos de Yodo/efectos adversos , Enfermedades del Aparato Lagrimal/tratamiento farmacológico , Aparato Lagrimal/patología , Traumatismos Experimentales por Radiación/tratamiento farmacológico , Resveratrol/farmacología , Animales , Antioxidantes/farmacología , Modelos Animales de Enfermedad , Femenino , Radioisótopos de Yodo/uso terapéutico , Aparato Lagrimal/metabolismo , Aparato Lagrimal/efectos de la radiación , Enfermedades del Aparato Lagrimal/diagnóstico , Enfermedades del Aparato Lagrimal/etiología , Estrés Oxidativo , Traumatismos Experimentales por Radiación/complicaciones , Traumatismos Experimentales por Radiación/diagnóstico , Ratas , Ratas Wistar
2.
Invest Ophthalmol Vis Sci ; 59(14): DES130-DES137, 2018 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-30481817

RESUMEN

The use of video display terminals (VDT) and staring at screens of technologic devices, including desktops, laptops, tablets, and smartphones have become ubiquitous in a wide range of age groups because of the rapid advance of network culture-mediated communications. The incidence of dry eye is particularly high in workers that work with VDT. To facilitate an understanding of the mechanisms of VDT-associated dry eye, as well as to develop novel treatment approaches, a VDT worker dry eye model was created. The procedure involved placing rats on a swing in combination with exposure to an evaporative environment. This animal model reveals that the blink frequency was reduced to one-third of the nonswing riding levels, which is similar to the results that have been reported by VDT users. Pathologic analysis of the lacrimal gland in this dry eye model showed that the decrease in tear secretion was accompanied by a decrease in the acinar cell number, and an enlargement of acinar cells was accompanied by filling with an increased volume of secretory vesicles and a loss of intracellular cell structure, suggesting the involvement of lacrimal hypofunction. An interventional study using this dry eye model showed that oral supplementation of some natural ingredients is a possible therapy for relieving symptoms of VDT-associated dry eye. Further investigations for the establishment of VDT use-associated dry eye models that may be used to evaluate ocular discomfort that mimic the condition in humans are needed to understand and modify this type of dry eye.


Asunto(s)
Terminales de Computador , Síndromes de Ojo Seco/etiología , Enfermedades Profesionales/etiología , Animales , Parpadeo/fisiología , Modelos Animales de Enfermedad , Síndromes de Ojo Seco/fisiopatología , Síndromes de Ojo Seco/terapia , Humanos , Enfermedades del Aparato Lagrimal/etiología , Enfermedades del Aparato Lagrimal/fisiopatología , Enfermedades Profesionales/fisiopatología , Enfermedades Profesionales/terapia , Fitoterapia , Lágrimas/fisiología
3.
Curr Eye Res ; 42(12): 1590-1596, 2017 12.
Artículo en Inglés | MEDLINE | ID: mdl-28937867

RESUMEN

PURPOSE: To evaluate protective effect of coenzyme Q10 (CoQ10) in lacrimal glands against high-dose radioactive iodine (RAI)-associated oxidative damage. MATERIALS AND METHODS: Thirty Wistar albino rats were randomly divided into three groups. Group 1 was the control group. Group 2 received 3 mCi/kg RAI via gastric gavage but no medication. Group 3 received 3 mCi/kg RAI via gastric gavage and 30 mg/kg/day CoQ10 intraperitoneally. CoQ10 was started at day one just before RAI administration and continued for five days. Seven days after RAI therapy, the animals were anesthetized and decapitated. Intraorbital (IG), extraorbital (EG), and Harderian (HG) lacrimal glands were removed bilaterally for histopathological and tissue cytokine level assessments. RESULTS: Abnormal lobular pattern, acinar fibrosis, lipofuscin-like accumulations, perivascular infiltration, cell size variation, abnormal cell outlines, irregular nucleus shapes in all lacrimal gland types (p < 0.05 for each), periductal fibrosis, periductal and periacinar fibrosis in EG (p = 0.01, 0.044, respectively) and in HG (p = 0.036, 0.044, respectively), periductal infiltration in HG (p = 0.039) and IG (p = 0.029), acinar atrophy in EG (p = 0.044), and cell shape variation in IG (p = 0.036) were observed more frequently in group 2 than in other groups. RAI caused significant increase in TNF-α, IL-6, nuclear factor kappa B, and total oxidant status, and decrease in IL-2, IL-10, and total antioxidant status levels (p < 0.05 for each). Addition of CoQ10 decreased all cytokine levels, increased nuclear factor kappa B levels more, and increased total antioxidant status levels significantly (p < 0.05 for each). CONCLUSIONS: RAI administration causes prominent inflammatory response in lacrimal glands. Addition of CoQ10 ameliorates the oxidative damage and protects lacrimal glands both in histopathological and tissue cytokine level assessments. Protection of lacrimal glands against oxidative damage may become a new era of CoQ10 use in the future.


Asunto(s)
Citocinas/metabolismo , Radioisótopos de Yodo/efectos adversos , Enfermedades del Aparato Lagrimal/prevención & control , Estrés Oxidativo/efectos de la radiación , Traumatismos Experimentales por Radiación/prevención & control , Ubiquinona/análogos & derivados , Vitaminas/uso terapéutico , Animales , Atrofia , Síndromes de Ojo Seco/etiología , Síndromes de Ojo Seco/metabolismo , Síndromes de Ojo Seco/patología , Síndromes de Ojo Seco/prevención & control , Fibrosis , Enfermedades del Aparato Lagrimal/etiología , Enfermedades del Aparato Lagrimal/metabolismo , Enfermedades del Aparato Lagrimal/patología , Traumatismos Experimentales por Radiación/etiología , Traumatismos Experimentales por Radiación/metabolismo , Traumatismos Experimentales por Radiación/patología , Ratas , Ratas Wistar , Ubiquinona/uso terapéutico
5.
Arch Ophthalmol ; 126(9): 1297-300, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-18779495

RESUMEN

A comfortable, anatomically based lacrimal sac abscess incision and drainage technique is described. The records of 52 patients were reviewed. The procedure was relieving and well tolerated because of adequate infraorbital and anterior ethmoidal nerve blocks. To promote rapid resolution, both components of the abscess were drained: the distended lacrimal sac and its associated submuscular pocket. The contiguous cavities were packed and allowed to heal by secondary intention. Of 49 cases, 39 (79.6%) were done as outpatient procedures and 41 (83.7%) were performed under locoregional anesthesia. Edema completely resolved by a median of 7 days. A repeat drainage procedure within 1 month was required in only 4 of 48 cases (8.3%). Fistulas and ectropion were not found. Four of 16 patients (25.0%) who did not eventually receive a definitive procedure (dacryocystorhinostomy or dacryocystectomy) developed a recurrent lacrimal sac abscess after complete resolution of the primary episode.


Asunto(s)
Absceso/cirugía , Drenaje/métodos , Enfermedades del Aparato Lagrimal/cirugía , Procedimientos Quirúrgicos Oftalmológicos , Absceso/diagnóstico por imagen , Absceso/etiología , Enfermedad Aguda , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Anestesia Local/métodos , Anestésicos Locales/administración & dosificación , Niño , Preescolar , Dacriocistitis/complicaciones , Epinefrina/administración & dosificación , Femenino , Humanos , Enfermedades del Aparato Lagrimal/diagnóstico por imagen , Enfermedades del Aparato Lagrimal/etiología , Lidocaína/administración & dosificación , Masculino , Persona de Mediana Edad , Propoxicaína/administración & dosificación , Estudios Retrospectivos , Tomografía Computarizada por Rayos X
6.
J Fr Ophtalmol ; 30(6): e15, 2007 Jun.
Artículo en Francés | MEDLINE | ID: mdl-17646742

RESUMEN

INTRODUCTION: Vitamin A deficiency occurs in the poor in developing countries and is one of the main causes of blindness by perforative corneal complications. It is a rare pathology in industrialized countries and it is associated with an absorption syndrome. The authors report the first case of hypovitaminosis A in a patient suffering from chronic and severe anorexia nervosa. CASE REPORT: The patient suffered from epiphora, photophobia, and hesperanopia. The ophthalmologic findings were keratoconjunctival xerosis with bilateral corneal ulcerations. The visual field showed a concentric bilateral restriction of isopters with tubular central vision, a similar aspect to retinitis pigmentosa. The ERG was modified with a b2 reduction and normal photopic and impaired scotopic responses. The fluorescein angiography was normal. The serum concentration of retinol confirmed the diagnosis of hypovitaminosis A. Corneoconjunctival improvement was obtained with vitamin supplementation, but no campimetric improvement was observed. DISCUSSION: The corneoconjunctival signs result from direct destruction of goblet cells, whereas the campimetric deficit is explained by a dysfunction of rod cells. Rhodopsin, necessary to the survival of the cell, cannot be renewed if retinol is not present, which causes a permanent bright light stimulation that is lethal for the photoreceptor. CONCLUSION: Vitamin A deficiency is rarely caused by psychiatric disease. Even if the main clinical finding is xerophthalmia with a high risk of keratomalacia, the visual prognosis can also be engaged by dysfunction of photoreceptors.


Asunto(s)
Anorexia Nerviosa/complicaciones , Úlcera de la Córnea/etiología , Enfermedades del Aparato Lagrimal/etiología , Fotofobia/etiología , Deficiencia de Vitamina A/etiología , Xeroftalmia/etiología , Adulto , Femenino , Humanos , Células Fotorreceptoras Retinianas Bastones/patología , Campos Visuales , Deficiencia de Vitamina A/diagnóstico , Deficiencia de Vitamina A/tratamiento farmacológico
7.
Neurol Sci ; 23(3): 107-12, 2002 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12391494

RESUMEN

The objective of this double-blind, randomized, placebo-controlled study was to test the efficacy of high-dose prednisone, administered as early as possible, in modifying the natural progression of Bell's palsy. Sixty-two consecutive patients, enrolled within 72 hours of facial palsy onset, were assigned to high dose intravenous prednisone in combination with intramuscular polyvitaminic therapy (group A) or polyvitaminic therapy alone (group B). Clinical grading of facial muscle strength and length of absence from work were evaluated. An early worsening of facial muscle strength was observed in controls, leading to the divergence in the trends of the grading scores in the two groups; this result was not confirmed in the long-term follow-up. Treated patients returned to work earlier than controls. In conclusion, early treatment based on high-dose corticosteroids slightly accelerates spontaneous improvement in Bell's palsy.


Asunto(s)
Antiinflamatorios/administración & dosificación , Parálisis de Bell/tratamiento farmacológico , Prednisona/administración & dosificación , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antiinflamatorios/efectos adversos , Parálisis de Bell/fisiopatología , Relación Dosis-Respuesta a Droga , Quimioterapia Combinada , Nervio Facial/efectos de los fármacos , Nervio Facial/fisiopatología , Femenino , Humanos , Hiperacusia/tratamiento farmacológico , Hiperacusia/etiología , Hiperacusia/fisiopatología , Enfermedades del Aparato Lagrimal/tratamiento farmacológico , Enfermedades del Aparato Lagrimal/etiología , Enfermedades del Aparato Lagrimal/fisiopatología , Masculino , Persona de Mediana Edad , Debilidad Muscular/tratamiento farmacológico , Debilidad Muscular/etiología , Debilidad Muscular/fisiopatología , Neuralgia/tratamiento farmacológico , Neuralgia/etiología , Neuralgia/fisiopatología , Prednisona/efectos adversos , Recuperación de la Función/efectos de los fármacos , Recuperación de la Función/fisiología , Trastornos del Gusto/tratamiento farmacológico , Trastornos del Gusto/etiología , Trastornos del Gusto/fisiopatología , Factores de Tiempo , Resultado del Tratamiento , Vitaminas/uso terapéutico
8.
Optometry ; 72(10): 634-40, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-11712630

RESUMEN

BACKGROUND: Mucus fishing syndrome (MFS) is a cascading cyclic condition characterized by continuous extraction of mucous strands from the eye. It is usually initiated by ocular irritation. In response to irritation, ocular surface cells produce excess mucus. A "snow balling" cycle begins when the patient extracts ("fishes") excess mucus from the ocular surface, thereby causing further irritation and a more-profound mucous discharge. To date, treatment includes eliminating the initiating element and educating the patient not to touch the eye when extracting the excess mucus, CASE REPORT: Presented is a case of mucus fishing syndrome initiated by dry eye. The patient's diagnosis, MFS, was identified by persistent mucous discharge, his admittance and demonstration of digitally extracting mucus from the ocular surface, and a characteristic rose bengal staining pattern. The conventional treatment initiated by using artificial tears for the dry eye condition and educating the patient not to touch the ocular surface did not provide relief from the excess mucous discharge. Therefore, a new approach to treatment was pursued. In order to break the cycle, a mucolytic agent and an antihistamine-mast cell stabilizer were prescribed, until the ocular surface healed. After treatment, the patient reported alleviation of symptoms and demonstrated improvement in ocular surface integrity by a profound reduction in rose bengal staining. CONCLUSION: Mucus fishing syndrome is challenging to resolve with conventional treatment because it requires a certain level of psychological tolerance and perseverance from the patient. By eliminating the present mucus and diminishing mucous production pharmacologically, the practitioner is able to remove the stimulus for digital extraction and thus accelerate ocular surface healing. We present a proposed new treatment option for patients who are refractory to conventional treatments.


Asunto(s)
Cistina/análogos & derivados , Cistina/uso terapéutico , Dibenzoxepinas/uso terapéutico , Antagonistas de los Receptores Histamínicos H1/uso terapéutico , Enfermedades del Aparato Lagrimal/tratamiento farmacológico , Moco/metabolismo , Quimioterapia Combinada , Síndromes de Ojo Seco/complicaciones , Humanos , Enfermedades del Aparato Lagrimal/diagnóstico , Enfermedades del Aparato Lagrimal/etiología , Enfermedades del Aparato Lagrimal/metabolismo , Masculino , Persona de Mediana Edad , Clorhidrato de Olopatadina , Rosa Bengala , Síndrome
9.
Med Pr ; 50(1): 25-9, 1999.
Artículo en Polaco | MEDLINE | ID: mdl-10399714

RESUMEN

Lacrimal fluid plays a very significant role in maintaining proper functions of conjuctivas, cornea and eyelids. The fluid is secreted by the main lacrimal gland and additional glands. It produces the so called preocular lacrimal film. A number of clinical tests, such as Chirmer's tests I and II, break-up-time (BUT), lysozyme, and flow tests are used in quantitative and qualitative analyses, as well as in the determination of the lacrimal film stability. The aim of work was to utilize these in assessing the lacrimal secretion and the lacrimal film stability in workers chronically exposed to petroleum derivatives. Fifty three workers from departments of acetobenzene, benzene and butadiene, phenol and acetone, sewage waters, asphalt oxidas, polyethylene and polypropylene, were eligible for the study (group I). During previous examinations, acquired disorders in colour perception were diagnosed in all the subjects by means of the Mansuella-Fansworth 100-Hue test. The age range was 25 to 56 years, with a mediane of 44.1 years +/- 6.5. Mean duration of employment was 22 years (SD +/- 8.25). The control group (group II) was composed of 28 men aged between 24 and 60 years with a median of 42.7 years +/- 6.3, never employed under conditions of exposure to toxic chemicals. On the right eye of each subject Schirmer's test was performed after instilling into the conjunctival sac 1-2 drops of Alcain solution according to Whitcher. Five min following anesthesia of the conjunctival sac, a standardised belt of blotting-paper with colour dampness markers Vidisic (Dr Mann Pharma GMBH, Germany) was placed in the vicinity of the external angle of the eye. After 5 min the degree of the belt dampness was measured in millimetres. After 30 min the break-up-time test was performed on the left eye. Fluorescein was released to conjunctival sac from a sterile belt of blotting-paper (Haag-Strait Co.). A slit lamp with cobalt filter was used to calculate time (in sec) that elapsed between opening of the lid slit and the first symptom of breaking-up the lacrimal film. The results obtained were presented in the form of arithmetic means and standard deviation values +/- SD. Schirmer's test was 13.40 +/- 7.43 mm in group 1, and 22.54 +/- 8.25 mm in the control group, mean values differed significantly, p < 0.01. Lacrimal film break-up-time was 16.30 +/- 6.19 sec in group 1, and 31.48 +/- 7.96 sec in the control group, mean values differed significantly, p < 0.01. In persons chronically exposed to petroleum derivatives, statistically significant decrease in lacrimal secretion, as well as shortening of lacrimal film break-up-time were found when compared with the control group.


Asunto(s)
Enfermedades del Aparato Lagrimal/etiología , Enfermedades Profesionales/etiología , Exposición Profesional/efectos adversos , Petróleo/efectos adversos , Adulto , Enfermedad Crónica , Humanos , Enfermedades del Aparato Lagrimal/diagnóstico , Masculino , Persona de Mediana Edad , Enfermedades Profesionales/diagnóstico
11.
Ophthalmic Surg ; 24(2): 123-4, 1993 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-8446348

RESUMEN

A 52-year-old woman developed persistent epiphora in her left eye after undergoing occlusion of the left puncta. Two attempts to reopen the puncta with a one-snip procedure and placement of punctal silicone plugs failed. The epiphora resolved and the puncta remained patent after the patient underwent a third one-snip procedure, supplemented with topical mitomycin during and after surgery.


Asunto(s)
Dacriocistorrinostomía , Mitomicinas/uso terapéutico , Administración Tópica , Quimioterapia Adyuvante , Femenino , Humanos , Enfermedad Iatrogénica , Enfermedades del Aparato Lagrimal/etiología , Obstrucción del Conducto Lagrimal/complicaciones , Obstrucción del Conducto Lagrimal/tratamiento farmacológico , Persona de Mediana Edad
13.
s.l; s.n; oct. 1976. 7 p.
No convencional en Inglés | SES-SP, HANSEN, HANSENIASE, SESSP-ILSLACERVO, SES-SP | ID: biblio-1240899

RESUMEN

Leprosy is a chronic systemic disease which gives rise to a variety eye lesions. It involves mainly the anterior segment of the eye. It is estimated that there are nearly 15 million or morwe leprosy patients in the world.


Asunto(s)
Humanos , Conjuntivitis/etiología , Enfermedades de los Párpados/cirugía , Enfermedades de los Párpados/etiología , Enfermedades de la Córnea/etiología , Enfermedades del Aparato Lagrimal/etiología , Lepra/complicaciones , Métodos , Oftalmopatías/etiología , Uveítis Anterior/etiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA